Pathologic and clinical outcomes after neoadjuvant modified FOLFIRINOX and gemcitabine and NAB-paclitaxel for pancreatic cancer. Article

Web of Science: 000863680303304

Cited authors

  • Markabawi D, Ianiro C, Burton J, Bolton N, Mizrahi J

Publication date

  • 2022

Published in

International Standard Serial Number (ISSN)

  • 0732-183X

Number of pages

  • 1

Start page

  • E16236

End page

  • E16236


  • 40


  • 16